Empowered Patient Podcast

Dr. Jason Tibbels , Chief Medical Officer at Lantern, discusses how healthcare quality measurement has evolved and why specialty care providers need to use patient-reported outcome tools to provide real-time feedback for continuous clinical improvement.  The challenge is to determine whether procedures are clinically appropriate and effective, capture what matters to patients, and document side ef...

Dr. Jason Tibbels , Chief Medical Officer at Lantern, discusses how healthcare quality measurement has evolved and why specialty care providers need to use patient-reported outcome tools to provide real-time feedback for continuous clinical improvement.  The challenge is to determine whether procedures are clinically appropriate and effective, capture what matters to patients, and document side ef...

Ross Donahue, Chief Administrative Officer at Guardian Recovery,  highlights the dangerous gap between the time veterans request medical treatment, particularly for mental health and substance abuse issues, and actually receiving the necessary care. Guardian Recovery is addressing the need to treat mental health crises by deploying a 24/7 response with availability of beds and in partnership with...

Ross Donahue, Chief Administrative Officer at Guardian Recovery,  highlights the dangerous gap between the time veterans request medical treatment, particularly for mental health and substance abuse issues, and actually receiving the necessary care. Guardian Recovery is addressing the need to treat mental health crises by deploying a 24/7 response with availability of beds and in partnership with...

Andy Parham , Chief Executive Officer at Brado AI,  has developed an AI platform that acts as an orchestration layer between patient demand and health system capacity.  The platform uses conversational AI and precision routing to match patients to the appropriate provider, reducing time to reaching the correct treatment. Utilizing this approach also provides an opportunity to optimize the use of e...

Andy Parham , Chief Executive Officer at Brado AI,  has developed an AI platform that acts as an orchestration layer between patient demand and health system capacity.  The platform uses conversational AI and precision routing to match patients to the appropriate provider, reducing time to reaching the correct treatment. Utilizing this approach also provides an opportunity to optimize the use of e...

Brian Kenah , Chief Technology Officer at EnableComp, specializes in complex claims and has developed an AI plaform boosting efficiency and quality by incorporating new codes and regulatory changes while learning from approval and denial patterns.  The ability to deliver predictive revenue intelligence enables hospitals to identify issues before claims are submitted, prevent denials and negotiate...

Brian Kenah , Chief Technology Officer at EnableComp, specializes in complex claims and has developed an AI plaform boosting efficiency and quality by incorporating new codes and regulatory changes while learning from approval and denial patterns.  The ability to deliver predictive revenue intelligence enables hospitals to identify issues before claims are submitted, prevent denials and negotiate...

Jeanne Vennella , Clinical Strategy Director at Canopy, shines a light on workplace violence in healthcare and the need to recognize the problem and implement solutions to reduce risk. The majority of violent incidents originate with patients, families, and visitors, often triggered by poor communication and the stress of receiving difficult news. Canopy offers a wearable duress button worn behind...

Jeanne Vennella , Clinical Strategy Director at Canopy, shines a light on workplace violence in healthcare and the need to recognize the problem and implement solutions to reduce risk. The majority of violent incidents originate with patients, families, and visitors, often triggered by poor communication and the stress of receiving difficult news. Canopy offers a wearable duress button worn behind...

Richard Foust , President and CEO of Mobia Medical, discusses their FDA-approved implantable neurostimulation technology designed to improve hand and arm function in ischemic stroke survivors. When paired with task-specific rehabilitation therapy, this process enhances neuroplasticity, allowing the brain to form stronger neural connections around areas affected by stroke. With clinical results sho...

Richard Foust , President and CEO of Mobia Medical, discusses their FDA-approved implantable neurostimulation technology designed to improve hand and arm function in ischemic stroke survivors. When paired with task-specific rehabilitation therapy, this process enhances neuroplasticity, allowing the brain to form stronger neural connections around areas affected by stroke. With clinical results sho...

Rae McMahan , Senior VP for Payer Solutions at Prescryptive,  points out how the surge in demand for GLP-1 medications has exposed the strengths and weaknesses of the pharmaceutical ecosystem.  Rae highlights the growing role of direct-to-patient and manufacturer-sponsored programs as an alternative to the traditional pharmacy benefits manager model. Looking ahead, there are opportunities to trans...

Rae McMahan , Senior VP for Payer Solutions at Prescryptive,  points out how the surge in demand for GLP-1 medications has exposed the strengths and weaknesses of the pharmaceutical ecosystem.  Rae highlights the growing role of direct-to-patient and manufacturer-sponsored programs as an alternative to the traditional pharmacy benefits manager model. Looking ahead, there are opportunities to trans...

John Hanna , President and CEO of CareDx, discussed how the company's blood-based molecular diagnostic testing is transforming patient monitoring for organ transplantation, HPV-driven cancers, and hematologic malignancies. These molecular tools provide early warning signals months ahead of conventional methods, enabling clinicians to intervene proactively rather than reactively. Longitudinal data...

John Hanna , President and CEO of CareDx, discussed how the company's blood-based molecular diagnostic testing is transforming patient monitoring for organ transplantation, HPV-driven cancers, and hematologic malignancies. These molecular tools provide early warning signals months ahead of conventional methods, enabling clinicians to intervene proactively rather than reactively. Longitudinal data...

Samantha Dale Strasser , VP of Strategy at Cellular Intelligence, is developing an AI-native platform to decode how cells communicate and signal with each other using a proprietary capsule technology to collect massive datasets on cellular behavior.  The data is used to train functional virtual cell signaling models that predict and control cell fate, accelerating drug discovery and regenerative m...

Samantha Dale Strasser , VP of Strategy at Cellular Intelligence, is developing an AI-native platform to decode how cells communicate and signal with each other using a proprietary capsule technology to collect massive datasets on cellular behavior.  The data is used to train functional virtual cell signaling models that predict and control cell fate, accelerating drug discovery and regenerative m...

Steve Beard , CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are mutually exclusive and emphasizes that expanding training opportunities is essential to provide compet...

Steve Beard , CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are mutually exclusive and emphasizes that expanding training opportunities is essential to provide compet...

Dr. John Friend , CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering immune evasion mechanisms and the tumor microenvironment. Their lead drug candidate is showing reduct...

Dr. John Friend , CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering immune evasion mechanisms and the tumor microenvironment. Their lead drug candidate is showing reduct...

Leo Petrossian , CEO of Kandu, discusses a groundbreaking approach to stroke recovery that uses an FDA-cleared, non-invasive EEG headset combined with a robotic glove that detects when a patient visualizes moving their impaired arm and simultaneously moves the arm mechanically. Traditional rehabilitation has treated the arm rather than the brain, which is the source of the damage. This brain-compu...

Leo Petrossian , CEO of Kandu, discusses a groundbreaking approach to stroke recovery that uses an FDA-cleared, non-invasive EEG headset combined with a robotic glove that detects when a patient visualizes moving their impaired arm and simultaneously moves the arm mechanically. Traditional rehabilitation has treated the arm rather than the brain, which is the source of the damage. This brain-compu...

Dr. Sandeep Palakodeti , Chief Medical Officer for Los Angeles-based Bold,  discusses the company's comprehensive approach to healthy aging which centers on movement, nutrition, and clinical care. Bold is supported by an AI-enabled platform that personalizes the patient experience and enables a hybrid approach for high-quality care.  A particular focus is the growing use of GLP-1 medications among...